These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9236853)

  • 1. Targeting c-myc in leukemia.
    Calabretta B; Skorski T
    Anticancer Drug Des; 1997 Jul; 12(5):373-81. PubMed ID: 9236853
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications.
    Calabretta B
    Cancer Res; 1991 Sep; 51(17):4505-10. PubMed ID: 1873794
    [No Abstract]   [Full Text] [Related]  

  • 3. MicroRNAs in leukemia.
    Croce C
    Clin Adv Hematol Oncol; 2006 Aug; 4(8):577-8. PubMed ID: 17099614
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination antigene therapy targeting c-myc and c-erbB(2) in the ovarian cancer COC(1) cell line.
    Fei R; Shaoyang L
    Gynecol Oncol; 2002 Apr; 85(1):40-4. PubMed ID: 11925118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide.
    Putney SD; Brown J; Cucco C; Lee R; Skorski T; Leonetti C; Geiser T; Calabretta B; Zupi G; Zon G
    Antisense Nucleic Acid Drug Dev; 1999 Oct; 9(5):451-8. PubMed ID: 10555152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
    Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.
    Simile MM; De Miglio MR; Muroni MR; Frau M; Asara G; Serra S; Muntoni MD; Seddaiu MA; Daino L; Feo F; Pascale RM
    Carcinogenesis; 2004 Mar; 25(3):333-41. PubMed ID: 14604889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inactivation of MYC for the treatment of cancer.
    Felsher DW; Bradon N
    Drug News Perspect; 2003; 16(6):370-4. PubMed ID: 12973448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DLX-7 homeobox gene regulates c-myc and GATA-1 gene expression in different stages respectively.
    Shimamoto T; Ohyashiki K; Takeshita K
    Int J Oncol; 1999 Aug; 15(2):307-13. PubMed ID: 10402242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells].
    Bian J; Zhang B; Chen S
    Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):10-4. PubMed ID: 11600998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells.
    Awwad RT; Do K; Stevenson H; Fu SW; Lo-Coco F; Costello M; Campbell CL; Berg PE
    Ann Hematol; 2008 Mar; 87(3):195-203. PubMed ID: 18026954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines.
    Cerutti J; Trapasso F; Battaglia C; Zhang L; Martelli ML; Visconti R; Berlingieri MT; Fagin JA; Santoro M; Fusco A
    Clin Cancer Res; 1996 Jan; 2(1):119-26. PubMed ID: 9816098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
    Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
    Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Targeting delivery effect of galactose receptor-mediated c-myc antisense oligonucleotide on human hepatocellular carcinoma cell line Bel-7402].
    Jiang JW; Zhang Y
    Ai Zheng; 2004 Nov; 23(11):1288-93. PubMed ID: 15522175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of myc promoter and telomerase activity and induction of delayed apoptosis by SYUIQ-5, a novel G-quadruplex interactive agent in leukemia cells.
    Liu JN; Deng R; Guo JF; Zhou JM; Feng GK; Huang ZS; Gu LQ; Zeng YX; Zhu XF
    Leukemia; 2007 Jun; 21(6):1300-2. PubMed ID: 17392822
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting Bcl-2 protein expression in solid tumors and hematologic malignancies with antisense oligonucleotides.
    Tolcher AW
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):635-42, 662. PubMed ID: 16167050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing oligonucleotide therapeutics for human leukemia.
    Gewirtz AM
    Anticancer Drug Des; 1997 Jul; 12(5):341-58. PubMed ID: 9236851
    [No Abstract]   [Full Text] [Related]  

  • 20. Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia.
    Cheng YC; Lin H; Huang MJ; Chow JM; Lin S; Liu HE
    Leuk Res; 2007 Oct; 31(10):1403-11. PubMed ID: 17445886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.